SPL 1.02% 9.7¢ starpharma holdings limited

Ann: US patent issued for DEP cabazitaxel nanoparticle, page-27

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,412 Posts.
    lightbulb Created with Sketch. 142
    Let’s hope so. Personally, someone who has recently lost a parent to that horrendous condition they call cancer, I, for one am hoping one of the big boys buys us out. I’m sure they could get our DEP portfolio to market as quickly as they want and start actually giving some people extra time and quality of life. $2 fine, I don’t care. If our tech is that good, then please stop stuffing around and get it done. The problem is, at the end of the day, it’s all about the $$. We all only have one life
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.